Current Report Filing (8-k)
July 20 2016 - 10:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
July 14, 2016
21
st
CENTURY ONCOLOGY
HOLDINGS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
333-170812
|
|
26-1747745
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
2270 Colonial Boulevard
Fort Myers, Florida
|
|
33907
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(239) 931-7254
(Registrants Telephone Number, including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 14, 2016, Scott Lawrence, a member of the Board of Directors (the Board) of 21st Century Oncology Holdings, Inc. (the Company), notified the Board of his decision to resign as a director of the Company, effective immediately. Mr. Lawrence had been a member of the Board since September 2014 and was a member of the Compensation Committee. Mr. Lawrences resignation was not due to any disagreement with the Company. The Company thanks him for his time and dedicated service.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
21
st
CENTURY ONCOLOGY HOLDINGS, INC.
|
|
|
|
|
|
Date: July
20
, 2016
|
By:
|
/s/ LeAnne M. Stewart
|
|
|
Name:
|
LeAnne M. Stewart
|
|
|
Title:
|
Chief Financial Officer
|
3
21st Century Oncology Holdings, (NYSE:ICC)
Historical Stock Chart
From Jun 2024 to Jul 2024
21st Century Oncology Holdings, (NYSE:ICC)
Historical Stock Chart
From Jul 2023 to Jul 2024